No Data
No Data
Armata Secures $4.65M DoD Funding To Advance AP-SA02 Trial For Staph Bacteremia, Topline Data Expected Q2 2025
Express News | Armata Pharmaceuticals Inc - Topline Data Expected Q2 2025 for Future Trial
Express News | Armata Pharmaceuticals Receives $4.65 Million of Additional Non-Dilutive Award Funding From the U.S. Department of Defense to Support Ongoing Disarm Clinical Trial of AP-SA02
Armata Pharmaceuticals | 10-K: FY2024 Annual Report
Armata Pharmaceuticals | 8-K: Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Results and Provides Corporate Update
Express News | Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Results and Provides Corporate Update